The FDA’s guidance on this issue will be extremely important. Read more
There have been a couple of recent developments in the Risperdal litigation occurring in Philadelphia since our update in July 2016. Read more
Lawyers in Beasley Allen’s Mass Torts Section are investigating claims on behalf of individuals and families injured by Invokana and Invokamet. Read more
The U.S. Food and Drug Administration (FDA) approved the use of Abilify for treating schizophrenic adults in 2002. Read more
Defects in Physiomesh were found only after it was put on the market. Read more
All new e-cigarette and similar products will be subject to FDA review and pre-market approval. Read more
Teething can be managed without prescription or over-the-counter remedies. Read more
If you need more information about the Xarelto litigation, contact David Byrne at 800-898-2034 or by email at David.Byrne@beasleyallen.com. Read more
The final rule includes antiseptic hand and body washes that contain one or more of the 19 active ingredients specified by the FDA. Read more
The FDA last month warned that any devices claiming to screen for ovarian cancer aren't backed by scientific proof. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.